Literature DB >> 1166891

Growth hormone catecholamines in affective disease.

D L Garver, G N Pandey, H Dekirmenjian, F Deleon-Jones.   

Abstract

The authors studied growth hormone (GH) release after insulin-induced hypoglycemia (HI) in relation to urinary MHPG, the major metabolite of central norepinephrine. There was a significant linear correlation of urinary MHPG levels and GH peaks after HI in unipolar depressed patients and in manic patients; however, GH peaks in manic patients shifted downward on the GH axis in comparison to the unipolar depressive patients. The authors suggest that such shifts in the GH response may occur as a result of abnormalities of other neurotransmitter systems also known to facilitate GH release.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1166891     DOI: 10.1176/ajp.132.11.1149

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  3 in total

1.  Acute psychologic and neuroendocrine effects of dextroamphetamine and methylphenidate.

Authors:  W A Brown; D P Corriveau; M H Ebert
Journal:  Psychopharmacology (Berl)       Date:  1978-07-06       Impact factor: 4.530

2.  Dopamine receptor alteration in schizophrenia: neuroendocrine evidence.

Authors:  J Rotrosen; B M Angrist; S Gershon; E J Sachar; F S Halpern
Journal:  Psychopharmacology (Berl)       Date:  1976-12-21       Impact factor: 4.530

3.  [Endocrinological prediction of the responsiveness of depressive patients to lofepramine (author's transl)].

Authors:  M Philipp; J Beyer; J Happ; U Krause
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1979-07-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.